/Merck%20%26%20Co%20Inc%20logo%20and%20pill-by%20viewimage%20via%20Shutterstock.jpg)
Based in Rahway, New Jersey, Merck & Co., Inc. (MRK), a global healthcare leader with a market cap of $284.5 billion, operates in the pharmaceutical and animal health sectors. The company is renowned for its diverse portfolio, including the PD-L1 inhibitor Keytruda, and engages in innovative collaborations and acquisitions to drive growth and enhance its product offerings.
Shares of the pharmaceutical giant have underperformed the broader market over the past 52 weeks. MRK has gained 5.9% over this time frame, while the broader S&P 500 Index ($SPX) has rallied 17%. In 2024, shares of MRK are up nearly 2%, lagging behind the SPX's 9.9% YTD returns.